Results
Fredun Pharmaceuticals H1 Net Profit Soars 94%
Fredun Pharmaceuticals reported unaudited H1 FY27 standalone results with 87% revenue growth to ₹495.88 crore.
Net profit surged 94% to ₹31.99 crore while EBITDA jumped 92% to ₹75.38 crore with margin
